Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Concurrent Chemoradiotherapy for High Risk Oral Cavity Cancer
NCT00201383Phase 3Completed
- Sponsor
- National Health Research Institutes
- Start
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in oral cavity squamous cell carcinoma (OCSCC), sponsored by National Health Research Institutes. Started Oct 1999; status: completed.
02
Drugs
cisplatin
03
Conditions
oral cavity squamous cell carcinoma (OCSCC)
Beyond the preview
Go deeper on NCT00201383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201383.